TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 187 filers reported holding TG THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.72 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $15,689,046 | -62.6% | 1,876,680 | +11.0% | 0.00% | -50.0% |
| Q2 2023 | $41,984,125 | +119.3% | 1,690,182 | +32.8% | 0.00% | +100.0% |
| Q1 2023 | $19,142,565 | +109.0% | 1,272,776 | +64.4% | 0.00% | +100.0% |
| Q4 2022 | $9,159,259 | +310.7% | 774,240 | +105.5% | 0.00% | – |
| Q3 2022 | $2,230,000 | -72.4% | 376,798 | -80.2% | 0.00% | -100.0% |
| Q2 2022 | $8,071,000 | -22.0% | 1,899,010 | +74.5% | 0.00% | 0.0% |
| Q1 2022 | $10,352,000 | -3.8% | 1,088,352 | +92.2% | 0.00% | 0.0% |
| Q4 2021 | $10,758,000 | -52.5% | 566,242 | -16.8% | 0.00% | -66.7% |
| Q3 2021 | $22,637,000 | +93.8% | 680,198 | +125.9% | 0.00% | +50.0% |
| Q2 2021 | $11,678,000 | +282.5% | 301,076 | +375.2% | 0.00% | – |
| Q1 2021 | $3,053,000 | -76.9% | 63,362 | -75.0% | 0.00% | -100.0% |
| Q4 2020 | $13,209,000 | +252.3% | 253,910 | +81.2% | 0.00% | +100.0% |
| Q3 2020 | $3,749,000 | +18.6% | 140,131 | -13.6% | 0.00% | 0.0% |
| Q2 2020 | $3,161,000 | +2.5% | 162,268 | -48.2% | 0.00% | 0.0% |
| Q1 2020 | $3,085,000 | -10.8% | 313,431 | +0.6% | 0.00% | 0.0% |
| Q4 2019 | $3,457,000 | +181.5% | 311,463 | +42.3% | 0.00% | – |
| Q3 2019 | $1,228,000 | +28.2% | 218,888 | +97.7% | 0.00% | – |
| Q2 2019 | $958,000 | +55.0% | 110,720 | +44.1% | 0.00% | – |
| Q1 2019 | $618,000 | -77.0% | 76,817 | -88.3% | 0.00% | -100.0% |
| Q4 2018 | $2,683,000 | +169.4% | 654,325 | +268.0% | 0.00% | – |
| Q3 2018 | $996,000 | -69.3% | 177,794 | -28.0% | 0.00% | -100.0% |
| Q2 2018 | $3,246,000 | +44.6% | 246,853 | +56.1% | 0.00% | 0.0% |
| Q1 2018 | $2,245,000 | +52.5% | 158,116 | -12.0% | 0.00% | – |
| Q4 2017 | $1,472,000 | +21.3% | 179,577 | +75.2% | 0.00% | – |
| Q3 2017 | $1,214,000 | +15.7% | 102,488 | -1.8% | 0.00% | – |
| Q2 2017 | $1,049,000 | -56.9% | 104,403 | -50.0% | 0.00% | – |
| Q1 2017 | $2,434,000 | +109.8% | 208,920 | -16.3% | 0.00% | – |
| Q4 2016 | $1,160,000 | +44.8% | 249,540 | +141.4% | 0.00% | – |
| Q3 2016 | $801,000 | +159.2% | 103,373 | +103.2% | 0.00% | – |
| Q2 2016 | $309,000 | -49.3% | 50,882 | -28.9% | 0.00% | – |
| Q1 2016 | $610,000 | +9.9% | 71,585 | +54.0% | 0.00% | – |
| Q4 2015 | $555,000 | -4.8% | 46,478 | -19.8% | 0.00% | – |
| Q3 2015 | $583,000 | -41.0% | 57,925 | -2.7% | 0.00% | – |
| Q2 2015 | $988,000 | -14.9% | 59,540 | -20.5% | 0.00% | – |
| Q1 2015 | $1,161,000 | +4.4% | 74,927 | +6.8% | 0.00% | – |
| Q4 2014 | $1,112,000 | +424.5% | 70,172 | +254.4% | 0.00% | – |
| Q3 2014 | $212,000 | +19.8% | 19,800 | +5.0% | 0.00% | – |
| Q2 2014 | $177,000 | -77.0% | 18,864 | -83.1% | 0.00% | – |
| Q1 2014 | $769,000 | +12716.7% | 111,438 | +6699.1% | 0.00% | – |
| Q4 2013 | $6,000 | -97.2% | 1,639 | -95.0% | 0.00% | – |
| Q2 2013 | $211,000 | – | 32,980 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 5,434,783 | $60,326,000 | 5.25% |
| RA Capital Management | 9,880,323 | $109,672,000 | 3.33% |
| BRIDGER MANAGEMENT, LLC | 1,907,492 | $21,173,000 | 1.53% |
| Eversept Partners, LP | 776,323 | $8,617,185 | 1.52% |
| Opaleye Management Inc. | 579,651 | $6,434,000 | 1.26% |
| Sofinnova Investments, Inc. | 811,292 | $9,006,000 | 0.65% |
| Ikarian Capital, LLC | 316,200 | $3,510,000 | 0.57% |
| ARMISTICE CAPITAL, LLC | 800,000 | $8,880,000 | 0.51% |
| 683 Capital Management, LLC | 398,271 | $4,421,000 | 0.51% |
| Frontier Wealth Management LLC | 196,750 | $2,184,000 | 0.35% |